Gen competitive analysis

Explore patent oppositions filed by Gen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 9, 2026
Patent NumberTitleApplicantOpposition Date
Rimegepant For Cgrp Related DisordersBIOHAVEN PHARMACEUTICAL HOLDINGMay 28, 2026
Methods Of Treating Hfpef Employing Dapagliflozin And Compositions Comprising The SameASTRAZENECAMay 20, 2026
Control Of An Asphalt Mixing PlantAMMANN SCHWEIZMay 20, 2026
Laminating Device For Rfid Electronic Tag Used For TireMESNACMay 13, 2026
Test Device For Testing Fluid-Conducting ComponentsRUD PREYMay 13, 2026
Cationic Lipids For Use In Lipid NanoparticlesACUITAS THERAPEUTICSMay 12, 2026
TireSUMITOMO RUBBER INDUSTRIESMay 7, 2026
TireSUMITOMO RUBBER INDUSTRIESMay 7, 2026
Brake Disc With Nickel-Free Steel Layer And Manufacturing MethodBREMBOApr 29, 2026
Brake Disc With Steel Layer With Reduced Nickel Content And Manufacturing MethodBREMBOApr 23, 2026

Explore Gen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 9, 2026
Patent NumberPublication DateTitleTotal Oppositions
Aug 6, 2025Torsional Protection System And Method For Wind Turbine1
Aug 6, 2025System And Methods For Determining A Quality Score For A Part Manufactured By An Additive Manufacturing Machine1
Jul 9, 2025Systems And Methods For Optimizing Operation Of A Wind Farm2
Jul 9, 2025Copper Loss Mitigation1
May 21, 2025A Method For Repairing A Turbine Component Wherein Damaged Material Is Removed And A Plug With Improved Material Properties Is Inserted And A Corresponding Repaired Component3
Apr 30, 2025Method For Preparing A Composition Comprising Highly Concentrated Antibodies By Ultrafiltration3
Apr 30, 2025Methods Of Treatment Of Cholestatic Diseases3
Apr 9, 2025Multispecific Antigen-Binding Molecule With Improved Internalization Characteristics1
Mar 26, 2025Treatment Of Breast Cancer Using Combination Therapies Comprising Gdc-9545 And Gdc-00771
Mar 5, 2025Aav Vectors For Retinal And Cns Gene Therapy1

Latest PTAB cases involving Gen

Discover the latest PTAB cases involving Gen, highlighting their recent legal challenges and patent disputes.

Last updated on: Jul 9, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Gen

IPR2026-00260May 26, 2026AMNEAL PHARMACEUTICALSGENENTECHPending
IPR2026-00270Feb 26, 2026SAREPTA THERAPEUTICSGENZYMEPending
IPR2026-00166Dec 2, 2025SAREPTA THERAPEUTICSGENZYMETerminated
IPR2026-00167Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00168Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00149Nov 25, 2025SAREPTA THERAPEUTICSGENZYMEInstitution Denied
IPR2026-00150Nov 25, 2025SAREPTA THERAPEUTICSGENZYMETrial Instituted
IPR2026-00022Oct 10, 2025GENERAC POWER SYSTEMSPSLCDiscretionary Denial
IPR2026-00023Oct 10, 2025GENERAC POWER SYSTEMSPSLCDiscretionary Denial
IPR2026-00024Oct 10, 2025GENERAC POWER SYSTEMSPSLCDiscretionary Denial

Peer Comparison New

IP litigation analysis comparing Gen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMGEN8143811
JAMES POOLE161 - - -
REGENERON PHARMACEUTICALS38110932
STRAWMAN372 - - -